Squamous cell carcinoma prevention in organ transplant recipients using topical treatments: a feasibility study (SPOT)

Trial Profile

Squamous cell carcinoma prevention in organ transplant recipients using topical treatments: a feasibility study (SPOT)

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Dec 2016

At a glance

  • Drugs Fluorouracil (Primary) ; Imiquimod (Primary)
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Acronyms SPOT
  • Most Recent Events

    • 02 Dec 2016 Status changed from recruiting to completed.
    • 13 Feb 2016 Accrual to date is 82% according to United Kingdom Clinical Research Network record.
    • 04 Dec 2015 Accrual to date is 80% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top